Moderna’s unique ‘Expression’ platform is based on Modified Messenger RNA Therapeutics, which can be encoded for virtually any known protein and designed to be taken up by the cells in specific tissues. The pioneering protein therapies at Moderna have significant implications for the treatment of a wide range of diseases that widely used technologies cannot cure
A forward-looking research and development organisation, Moderna is pioneering the next generation of drug development, using messenger RNA (mRNA). The idea is based on the belief that mRNA can assist the human body in generating protein, which in turn contributes to beneficial activity in and around cells. Moderna has built a unique and diverse workforce capable of focusing and developing the very best technology, working with the latest advances in mRNA understanding.